Julius E. Linn Jr., M.D., who died Aug.

These new findings help simplify the treatment for patients with syphilis.

With the growth of clinical research and trials at the University of Alabama at Birmingham (UAB) and to meet the evolving needs of investigators and study teams, two longstanding support programs—the UAB Department of Medicine’s Clinical Research Enterprise (CRE) and the Center for Clinical and Translational Science (CCTS) Clinical Research Support Program (CRSP)—have merged to form the Clinical Research Support Enterprise (CReSt).

Nathan Shock Centers across the nation are funded by the National Institute on Aging to provide leadership in the pursuit of basic research into the biology of aging.

Joseph Johnson, M.D., associate professor in the Department of Orthopaedic Surgery at the University of Alabama at Birmingham (UAB), has been awarded a Pilot and Feasibility Study grant from the UAB Comprehensive Arthritis, Musculoskeletal, Bone and Autoimmunity Center (CAMBAC).

Starting this fall, the Developing Emerging Administrative Leaders program will be managed by UAB’s HR Learning and Development team, continuing DEAL’s legacy as a transformative, career-accelerating experience for high-potential staff of UAB and UAB Medicine. Applications for the 2026 cohort are open now.

Amy Warriner, M.D., professor in the Department of Medicine, has been named the 2025 recipient of the Brewer-Heslin Award for Professionalism in Medicine.

After six years of pain, fatigue, and unanswered questions, Army veteran Jason Hall finally found hope through UAB’s Undiagnosed Diseases Program, which identified his condition and provided life-changing treatment within days. Today, Hall has regained his strength, mobility, and independence—and encourages others to keep searching for answers.

Bassel El-Rayes, M.D., professor in the division of Hematology and Oncology, has been named the latest recipient of the school’s Featured Discovery Award. This recognition celebrates significant research contributions made by faculty and highlights the impact of their scientific advancements.

The JAMA article is potentially practice-changing by enabling a diagnosis of COPD in individuals without airflow obstruction.

A new study led by UAB Comprehensive Diabetes Center Associate Scientist Fernando Bril, M.D., provides the first evidence that MASLD prevalence is beginning to decrease in adults with diabetes in the U.S. for the first time in decades.

Jackson says she experienced almost every symptom and complication of diabetes and CKD, and she spent two decades of her life constantly managing her condition.

A recent study authored by UAB researchers in the departments of Neurology, Medicine, and Epidemiology analyzed a decade of data to reveal that lack of access to stroke-related clinical trials may limit access to innovative treatments in geographic regions with high stroke burdens.

Tumor therapy with immune checkpoint blockers may be improved by fine-tuning Gfi1 in CD8+ T cells.

After a national search, Mark Dransfield, M.D., has been appointed chair of the UAB Department of Medicine, effective Sept. 1, 2025.

The University-Wide Interdisciplinary Research Center focuses on the involvement of community members, organizations and patients as partners in research and interventions with a mission to prevent disease and improve health for all.

In the face of a bacterium that easily resists common antibiotics, members of UAB established testing to identify it in human disease. Mycoplasma, that is.

UAB researchers report that carriers of specific genetic variants face significantly elevated risks of heart failure, cardiomyopathy and arrhythmia, underscoring the potential benefits of targeted genetic screening.

T-bet expression is required for persistence of memory B cells that have rapid differentiation potential to become antibody-producing plasma cells in response to a second infection.

It is never too late for individuals to take steps to help manage their health as they age.

The finding of TREM2 as a critical regulator of macrophage-mediated fibrosis makes it a promising therapeutic target for intervention for lung fibrotic disease.

The American Heart Association’s PREVENT CVD risk equation is designed to help predict a person’s risk of a cardiovascular event during their lifetime.

Congratulations to the 19 faculty and staff leaders who completed UAB’s leadership development program this month. Meet the graduates and see the requirements for the 2025-2026 cohort; nominations open in June.

A study published in December 2024 demonstrates how natural language processing techniques, combined with dedicated human personnel, can flag unusual findings in radiology images and connect patients with follow-up care. The work, pioneered in nodules on the adrenal glands, has many applications, the researchers say.

A 3D printer for prosthetics, navigation for patients on dialysis and a new electron microscope are three of the 11 projects to receive funding. The HSF-GEF faculty grants program is a way for UAB to support innovative ideas from its researchers and clinicians.

The 2024 honorees for the President’s Award for Excellence in Teaching represent each school, the College of Arts and Sciences, the Honors College, and the Graduate School.

The Stimulating Access to Research in Residency program, funded by the National Institute of Allergy and Infectious Diseases, is designed to help address the shortage of physician-scientists nationwide.

J. Claude Bennett, M.D., who served as UAB president from 1993 to 1996, passed away on Aug.

The facility, one of 15 shared resource labs at UAB and among the busiest, is one of a handful of leading labs to be recognized by the International Society for Advancement of Cytometry, or ISAC.

Vern Bush, Kevin Davis and Brittany Martin are the first-quarter 2024 honorees of the UAB Values in Action Program. Nominations for second-quarter 2024 honorees are open through April 24.